Background: In May 2012, the US Preventive Services Task Force assigned prostate-specific antigen-based screening a grade D recommendation, advising against screening at any age. Our objective was to
Clinical characteristics of men diagnosed with prostate cancer who underwent radical prostatectomy for clinically localized prostate cancer in HPFS, PHS, and the JH RRP cohort.
